Download PDF
Semin Respir Crit Care Med 2012; 33(05): 533-542
DOI: 10.1055/s-0032-1325162
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Diffuse Lung Diseases in Cigarette Smokers

Robert Vassallo
1   Division of Pulmonary and Critical Care Medicine, Mayo Clinic College of Medicine, Rochester, Minnesota
› Author Affiliations
Further Information

Publication History

Publication Date:
21 September 2012 (online)

    Permissions and Reprints

Abstract

Cigarette smoking is a recognized causative agent or precipitant of specific diffuse lung diseases characterized by bronchiolar and interstitial lung inflammation. Respiratory bronchiolitis-associated interstitial lung disease and pulmonary Langerhans cell histiocytosis are now considered smoking-induced diffuse lung diseases. Desquamative interstitial pneumonia is also recognized as a smoking-induced interstitial pneumonia in most cases. These disorders affect relatively young adult smokers and may be progressive. Although distinguishable by histopathological and radiographic features, significant overlap occurs in many cases with chest radiography and lung histology showing overlapping features of smoking-related bronchiolar and interstitial lung injury. Cigarette smoking is also recognized as an important precipitant of many acute eosinophilic pneumonia cases. Smokers are at higher risk of developing fibrotic interstitial lung diseases such as idiopathic pulmonary fibrosis and rheumatoid arthritis–associated interstitial lung disease. Certain smokers also develop combined emphysema and lung fibrosis. The avoidance of primary and second-hand cigarette smoke is a critical component of management for patients afflicted with these smoking-induced diffuse lung diseases. The role of corticosteroids and other immunosuppressive treatments in the management of smoking-related interstitial lung diseases remains poorly defined and should be reserved for individuals with progressive disease despite smoking cessation. Understanding mechanisms by which tobacco induces diffuse lung pathology is critical in the pursuit of novel therapeutic approaches for these diseases.

Keywords

respiratory bronchiolitis - desquamative interstitial pneumonia - interstitial lung disease - smoking - pulmonary Langerhans cell histiocytosis - acute eosinophilic pneumonia.
 

  • References

  • 1 Ryu JH, Myers JL, Capizzi SA, Douglas WW, Vassallo R, Decker PA. Desquamative interstitial pneumonia and respiratory bronchiolitis-associated interstitial lung disease. Chest 2005; 127 (1) 178-184
    CrossrefPubMedGoogle Scholar
  • 2 Vassallo R, Ryu JH, Schroeder DR, Decker PA, Limper AH. Clinical outcomes of pulmonary Langerhans'-cell histiocytosis in adults. N Engl J Med 2002; 346 (7) 484-490
    CrossrefPubMedGoogle Scholar
  • 3 Moon J, du Bois RM, Colby TV, Hansell DM, Nicholson AG. Clinical significance of respiratory bronchiolitis on open lung biopsy and its relationship to smoking related interstitial lung disease. Thorax 1999; 54 (11) 1009-1014
    CrossrefPubMedGoogle Scholar
  • 4 Niewoehner DE, Kleinerman J, Rice DB. Pathologic changes in the peripheral airways of young cigarette smokers. N Engl J Med 1974; 291 (15) 755-758
    CrossrefPubMedGoogle Scholar
  • 5 Remy-Jardin M, Remy J, Gosselin B, Becette V, Edme JL. Lung parenchymal changes secondary to cigarette smoking: pathologic-CT correlations. Radiology 1993; 186 (3) 643-651
    CrossrefPubMedGoogle Scholar
  • 6 Fraig M, Shreesha U, Savici D, Katzenstein AL. Respiratory bronchiolitis: a clinicopathologic study in current smokers, ex-smokers, and never-smokers. Am J Surg Pathol 2002; 26 (5) 647-653
    CrossrefPubMedGoogle Scholar
  • 7 Myers JL, Veal Jr CF, Shin MS, Katzenstein AL. Respiratory bronchiolitis causing interstitial lung disease: a clinicopathologic study of six cases. Am Rev Respir Dis 1987; 135 (4) 880-884
    CrossrefPubMedGoogle Scholar
  • 8 Yousem SA, Colby TV, Gaensler EA. Respiratory bronchiolitis-associated interstitial lung disease and its relationship to desquamative interstitial pneumonia. Mayo Clin Proc 1989; 64 (11) 1373-1380
    CrossrefPubMedGoogle Scholar
  • 9 Portnoy J, Veraldi KL, Schwarz MI , et al. Respiratory bronchiolitis-interstitial lung disease: long-term outcome. Chest 2007; 131 (3) 664-671
    CrossrefPubMedGoogle Scholar
  • 10 Mavridou D, Laws D. Respiratory bronchiolitis associated interstitial lung disease (RB-ILD): a case of an acute presentation. Thorax 2004; 59 (10) 910-911
    CrossrefPubMedGoogle Scholar
  • 11 Nakanishi M, Demura Y, Mizuno S , et al. Changes in HRCT findings in patients with respiratory bronchiolitis-associated interstitial lung disease after smoking cessation. Eur Respir J 2007; 29 (3) 453-461
    CrossrefPubMedGoogle Scholar
  • 12 Ryu JH. Classification and approach to bronchiolar diseases. Curr Opin Pulm Med 2006; 12 (2) 145-151
    CrossrefPubMedGoogle Scholar
  • 13 Craig PJ, Wells AU, Doffman S , et al. Desquamative interstitial pneumonia, respiratory bronchiolitis and their relationship to smoking. Histopathology 2004; 45 (3) 275-282
    CrossrefPubMedGoogle Scholar
  • 14 Liebow AA, Steer A, Billingsley JG. Desquamative interstitial pneumonia. Am J Med 1965; 39: 369-404
    CrossrefPubMedGoogle Scholar
  • 15 Flores-Franco RA, Luevano-Flores E, Gaston-Ramirez C. Sirolimus-associated desquamative interstitial pneumonia. Respiration 2007; 74 (2) 237-238
    CrossrefPubMedGoogle Scholar
  • 16 Lougheed MD, Roos JO, Waddell WR, Munt PW. Desquamative interstitial pneumonitis and diffuse alveolar damage in textile workers. Potential role of mycotoxins. Chest 1995; 108 (5) 1196-1200
    CrossrefPubMedGoogle Scholar
  • 17 Iskandar SB, McKinney LA, Shah L, Roy TM, Byrd Jr RP. Desquamative interstitial pneumonia and hepatitis C virus infection: a rare association. South Med J 2004; 97 (9) 890-893
    CrossrefPubMedGoogle Scholar
  • 18 Patchefsky AS, Fraimow W, Hoch WS. Desquamative interstitial pneumonia. Pathological findings and follow-up in 13 patients. Arch Intern Med 1973; 132 (2) 222-225
    CrossrefPubMedGoogle Scholar
  • 19 Matsuo K, Tada S, Kataoka M , et al. Spontaneous remission of desquamative interstitial pneumonia. Intern Med 1997; 36 (10) 728-731
    CrossrefPubMedGoogle Scholar
  • 20 Flusser G, Gurman G, Zirkin H, Prinslo I, Heimer D. Desquamative interstitial pneumonitis causing acute respiratory failure, responsive only to immunosuppressants. Respiration 1991; 58 (5-6) 324-326
    CrossrefPubMedGoogle Scholar
  • 21 Verleden GM, Sels F, Van Raemdonck D, Verbeken EK, Lerut T, Demedts M. Possible recurrence of desquamative interstitial pneumonitis in a single lung transplant recipient. Eur Respir J 1998; 11 (4) 971-974
    CrossrefPubMedGoogle Scholar
  • 22 Agostini C, Albera C, Bariffi F , et al; Registro Italiano Pneumopatie Infiltrative Diffuse. First report of the Italian register for diffuse infiltrative lung disorders (RIPID). Monaldi Arch Chest Dis 2001; 56 (4) 364-368
    PubMedGoogle Scholar
  • 23 Friedman PJ, Liebow AA, Sokoloff J. Eosinophilic granuloma of lung: clinical aspects of primary histiocytosis in the adult. Medicine (Baltimore) 1981; 60 (6) 385-396
    CrossrefPubMedGoogle Scholar
  • 24 Travis WD, Borok Z, Roum JH , et al. Pulmonary Langerhans cell granulomatosis (histiocytosis X): a clinicopathologic study of 48 cases. Am J Surg Pathol 1993; 17 (10) 971-986
    CrossrefPubMedGoogle Scholar
  • 25 Tazi A, Bonay M, Bergeron A, Grandsaigne M, Hance AJ, Soler P. Role of granulocyte-macrophage colony stimulating factor (GM-CSF) in the pathogenesis of adult pulmonary histiocytosis X. Thorax 1996; 51 (6) 611-614
    CrossrefPubMedGoogle Scholar
  • 26 Vassallo R, Walters PR, Lamont J, Kottom TJ, Yi ES, Limper AH. Cigarette smoke promotes dendritic cell accumulation in COPD; a Lung Tissue Research Consortium study. Respir Res 2010; 11: 45
    CrossrefPubMedGoogle Scholar
  • 27 Robays LJ, Lanckacker EA, Moerloose KB , et al. Concomitant inhalation of cigarette smoke and aerosolized protein activates airway dendritic cells and induces allergic airway inflammation in a TLR-independent way. J Immunol 2009; 183 (4) 2758-2766
    CrossrefPubMedGoogle Scholar
  • 28 Prasse A, Stahl M, Schulz G , et al. Essential role of osteopontin in smoking-related interstitial lung diseases. Am J Pathol 2009; 174 (5) 1683-1691
    CrossrefPubMedGoogle Scholar
  • 29 Yousem SA, Colby TV, Chen YY, Chen WG, Weiss LM. Pulmonary Langerhans' cell histiocytosis: molecular analysis of clonality. Am J Surg Pathol 2001; 25 (5) 630-636
    CrossrefPubMedGoogle Scholar
  • 30 Crausman RS, Jennings CA, Tuder RM, Ackerson LM, Irvin CG, King Jr TE. Pulmonary histiocytosis X: pulmonary function and exercise pathophysiology. Am J Respir Crit Care Med 1996; 153 (1) 426-435
    CrossrefPubMedGoogle Scholar
  • 31 Fartoukh M, Humbert M, Capron F , et al. Severe pulmonary hypertension in histiocytosis X. Am J Respir Crit Care Med 2000; 161 (1) 216-223
    CrossrefPubMedGoogle Scholar
  • 32 Moore AD, Godwin JD, Müller NL , et al. Pulmonary histiocytosis X: comparison of radiographic and CT findings. Radiology 1989; 172 (1) 249-254
    CrossrefPubMedGoogle Scholar
  • 33 Brauner MW, Grenier P, Mouelhi MM, Mompoint D, Lenoir S. Pulmonary histiocytosis X: evaluation with high-resolution CT. Radiology 1989; 172 (1) 255-258
    CrossrefPubMedGoogle Scholar
  • 34 Brauner MW, Grenier P, Tijani K, Battesti JP, Valeyre D. Pulmonary Langerhans cell histiocytosis: evolution of lesions on CT scans. Radiology 1997; 204 (2) 497-502
    CrossrefPubMedGoogle Scholar
  • 35 Krajicek BJ, Ryu JH, Hartman TE, Lowe VJ, Vassallo R. Abnormal fluorodeoxyglucose PET in pulmonary Langerhans cell histiocytosis. Chest 2009; 135 (6) 1542-1549
    CrossrefPubMedGoogle Scholar
  • 36 Kaste SC, Rodriguez-Galindo C, McCarville ME, Shulkin BL. PET-CT in pediatric Langerhans cell histiocytosis. Pediatr Radiol 2007; 37 (7) 615-622
    CrossrefPubMedGoogle Scholar
  • 37 Auerswald U, Barth J, Magnussen H. Value of CD-1-positive cells in bronchoalveolar lavage fluid for the diagnosis of pulmonary histiocytosis X. Lung 1991; 169 (6) 305-309
    CrossrefPubMedGoogle Scholar
  • 38 Housini I, Tomashefski Jr JF, Cohen A, Crass J, Kleinerman J. Transbronchial biopsy in patients with pulmonary eosinophilic granuloma: comparison with findings on open lung biopsy. Arch Pathol Lab Med 1994; 118 (5) 523-530
    PubMedGoogle Scholar
  • 39 Colby TV, Lombard C. Histiocytosis X in the lung. Hum Pathol 1983; 14 (10) 847-856
    CrossrefPubMedGoogle Scholar
  • 40 Lau SK, Chu PG, Weiss LM. Immunohistochemical expression of Langerin in Langerhans cell histiocytosis and non-Langerhans cell histiocytic disorders. Am J Surg Pathol 2008; 32 (4) 615-619
    CrossrefPubMedGoogle Scholar
  • 41 Vassallo R, Jensen EA, Colby TV , et al. The overlap between respiratory bronchiolitis and desquamative interstitial pneumonia in pulmonary Langerhans cell histiocytosis: high-resolution CT, histologic, and functional correlations. Chest 2003; 124 (4) 1199-1205
    CrossrefPubMedGoogle Scholar
  • 42 Mogulkoc N, Veral A, Bishop PW, Bayindir U, Pickering CA, Egan JJ. Pulmonary Langerhans' cell histiocytosis: radiologic resolution following smoking cessation. Chest 1999; 115 (5) 1452-1455
    CrossrefPubMedGoogle Scholar
  • 43 Negrin-Dastis S, Butenda D, Dorzee J, Fastrez J, d'Odémont JP. Complete disappearance of lung abnormalities on high-resolution computed tomography: a case of histiocytosis X. Can Respir J 2007; 14 (4) 235-237
    PubMedGoogle Scholar
  • 44 Von Essen S, West W, Sitorius M, Rennard SI. Complete resolution of roentgenographic changes in a patient with pulmonary histiocytosis X. Chest 1990; 98 (3) 765-767
    CrossrefPubMedGoogle Scholar
  • 45 Pardanani A, Phyliky RL, Li CY, Tefferi A. 2-Chlorodeoxyadenosine therapy for disseminated Langerhans cell histiocytosis. Mayo Clin Proc 2003; 78 (3) 301-306
    CrossrefPubMedGoogle Scholar
  • 46 Lazor R, Etienne-Mastroianni B, Khouatra C, Tazi A, Cottin V, Cordier JF. Progressive diffuse pulmonary Langerhans cell histiocytosis improved by cladribine chemotherapy. Thorax 2009; 64 (3) 274-275
    CrossrefPubMedGoogle Scholar
  • 47 Saven A, Burian C. Cladribine activity in adult Langerhans-cell histiocytosis. Blood 1999; 93 (12) 4125-4130
    CrossrefPubMedGoogle Scholar
  • 48 Aerni MR, Aubry MC, Myers JL, Vassallo R. Complete remission of nodular pulmonary Langerhans cell histiocytosis lesions induced by 2-chlorodeoxyadenosine in a non-smoker. Respir Med 2008; 102 (2) 316-319
    CrossrefPubMedGoogle Scholar
  • 49 Mendez JL, Nadrous HF, Vassallo R, Decker PA, Ryu JH. Pneumothorax in pulmonary Langerhans cell histiocytosis. Chest 2004; 125 (3) 1028-1032
    CrossrefPubMedGoogle Scholar
  • 50 Chaowalit N, Pellikka PA, Decker PA , et al. Echocardiographic and clinical characteristics of pulmonary hypertension complicating pulmonary Langerhans cell histiocytosis. Mayo Clin Proc 2004; 79 (10) 1269-1275
    CrossrefPubMedGoogle Scholar
  • 51 Delobbe A, Durieu J, Duhamel A, Wallaert B. Determinants of survival in pulmonary Langerhans' cell granulomatosis (histiocytosis X). Groupe d'Etude en Pathologie Interstitielle de la Société de Pathologie Thoracique du Nord. Eur Respir J 1996; 9 (10) 2002-2006
    CrossrefPubMedGoogle Scholar
  • 52 Gabbay E, Dark JH, Ashcroft T , et al. Recurrence of Langerhans' cell granulomatosis following lung transplantation. Thorax 1998; 53 (4) 326-327
    CrossrefPubMedGoogle Scholar
  • 53 Allen JN, Pacht ER, Gadek JE, Davis WB. Acute eosinophilic pneumonia as a reversible cause of noninfectious respiratory failure. N Engl J Med 1989; 321 (9) 569-574
    CrossrefPubMedGoogle Scholar
  • 54 Shorr AF, Scoville SL, Cersovsky SB , et al. Acute eosinophilic pneumonia among US Military personnel deployed in or near Iraq. JAMA 2004; 292 (24) 2997-3005
    CrossrefPubMedGoogle Scholar
  • 55 Watanabe K, Fujimura M, Kasahara K , et al. Acute eosinophilic pneumonia following cigarette smoking: a case report including cigarette-smoking challenge test. Intern Med 2002; 41 (11) 1016-1020
    CrossrefPubMedGoogle Scholar
  • 56 Al-Saieg N, Moammar O, Kartan R. Flavored cigar smoking induces acute eosinophilic pneumonia. Chest 2007; 131 (4) 1234-1237
    CrossrefPubMedGoogle Scholar
  • 57 Shiota Y, Kawai T, Matsumoto H , et al. Acute eosinophilic pneumonia following cigarette smoking. Intern Med 2000; 39 (10) 830-833
    CrossrefPubMedGoogle Scholar
  • 58 Philit F, Etienne-Mastroïanni B, Parrot A, Guérin C, Robert D, Cordier JF. Idiopathic acute eosinophilic pneumonia: a study of 22 patients. Am J Respir Crit Care Med 2002; 166 (9) 1235-1239
    CrossrefPubMedGoogle Scholar
  • 59 Hirai K, Yamazaki Y, Okada K, Furuta S, Kubo K. Acute eosinophilic pneumonia associated with smoke from fireworks. Intern Med 2000; 39 (5) 401-403
    CrossrefPubMedGoogle Scholar
  • 60 Miki K, Miki M, Nakamura Y , et al. Early-phase neutrophilia in cigarette smoke-induced acute eosinophilic pneumonia. Intern Med 2003; 42 (9) 839-845
    CrossrefPubMedGoogle Scholar
  • 61 Miki K, Miki M, Okano Y , et al. Cigarette smoke-induced acute eosinophilic pneumonia accompanied with neutrophilia in the blood. Intern Med 2002; 41 (11) 993-996
    CrossrefPubMedGoogle Scholar
  • 62 Fujimura M, Yasui M, Shinagawa S, Nomura M, Matsuda T. Bronchoalveolar lavage cell findings in three types of eosinophilic pneumonia: acute, chronic and drug-induced eosinophilic pneumonia. Respir Med 1998; 92 (5) 743-749
    CrossrefPubMedGoogle Scholar
  • 63 Jeong YJ, Kim KI, Seo IJ , et al. Eosinophilic lung diseases: a clinical, radiologic, and pathologic overview. Radiographics 2007; 27 (3) 617-637 , discussion 637–639
    CrossrefPubMedGoogle Scholar
  • 64 Nakanishi M, Okamura S, Demura Y, Ishizaki T, Miyamori I, Itoh H. Acute eosinophilic pneumonia with positive response to smoking challenge test, suggesting the involvement of health food [in Japanese]. Nihon Kokyuki Gakkai Zasshi 2001; 39 (5) 357-362
    PubMedGoogle Scholar
  • 65 Baumgartner KB, Samet JM, Stidley CA, Colby TV, Waldron JA. Cigarette smoking: a risk factor for idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 1997; 155 (1) 242-248
    CrossrefPubMedGoogle Scholar
  • 66 Miyake Y, Sasaki S, Yokoyama T , et al. Occupational and environmental factors and idiopathic pulmonary fibrosis in Japan. Ann Occup Hyg 2005; 49 (3) 259-265
    CrossrefPubMedGoogle Scholar
  • 67 Antoniou KM, Hansell DM, Rubens MB , et al. Idiopathic pulmonary fibrosis: outcome in relation to smoking status. Am J Respir Crit Care Med 2008; 177 (2) 190-194
    CrossrefPubMedGoogle Scholar
  • 68 Wolfe F. The effect of smoking on clinical, laboratory, and radiographic status in rheumatoid arthritis. J Rheumatol 2000; 27 (3) 630-637
    PubMedGoogle Scholar
  • 69 Luukkainen R, Saltyshev M, Pakkasela R, Nordqvist E, Huhtala H, Hakala M. Relationship of rheumatoid factor to lung diffusion capacity in smoking and non-smoking patients with rheumatoid arthritis. Scand J Rheumatol 1995; 24 (2) 119-120
    CrossrefPubMedGoogle Scholar
  • 70 King Jr TE, Tooze JA, Schwarz MI, Brown KR, Cherniack RM. Predicting survival in idiopathic pulmonary fibrosis: scoring system and survival model. Am J Respir Crit Care Med 2001; 164 (7) 1171-1181
    CrossrefPubMedGoogle Scholar
  • 71 Cottin V, Le Pavec J, Prévot G , et al; GERM”O”P. Pulmonary hypertension in patients with combined pulmonary fibrosis and emphysema syndrome. Eur Respir J 2010; 35 (1) 105-111
    CrossrefPubMedGoogle Scholar
  • 72 Mejía M, Carrillo G, Rojas-Serrano J , et al. Idiopathic pulmonary fibrosis and emphysema: decreased survival associated with severe pulmonary arterial hypertension. Chest 2009; 136 (1) 10-15
    CrossrefPubMedGoogle Scholar
  • 73 Saag KG, Kolluri S, Koehnke RK , et al. Rheumatoid arthritis lung disease: determinants of radiographic and physiologic abnormalities. Arthritis Rheum 1996; 39 (10) 1711-1719
    CrossrefPubMedGoogle Scholar
  • 74 Klareskog L, Stolt P, Lundberg K , et al. A new model for an etiology of rheumatoid arthritis: smoking may trigger HLA-DR (shared epitope)-restricted immune reactions to autoantigens modified by citrullination. Arthritis Rheum 2006; 54 (1) 38-46
    CrossrefPubMedGoogle Scholar
  • 75 Voigt LF, Koepsell TD, Nelson JL, Dugowson CE, Daling JR. Smoking, obesity, alcohol consumption, and the risk of rheumatoid arthritis. Epidemiology 1994; 5 (5) 525-532
    PubMedGoogle Scholar
  • 76 Hutchinson D, Shepstone L, Moots R, Lear JT, Lynch MP. Heavy cigarette smoking is strongly associated with rheumatoid arthritis (RA), particularly in patients without a family history of RA. Ann Rheum Dis 2001; 60 (3) 223-227
    CrossrefPubMedGoogle Scholar
  • 77 Makrygiannakis D, Hermansson M, Ulfgren AK , et al. Smoking increases peptidylarginine deiminase 2 enzyme expression in human lungs and increases citrullination in BAL cells. Ann Rheum Dis 2008; 67 (10) 1488-1492
    CrossrefPubMedGoogle Scholar
  • 78 Wang RD, Wright JL, Churg A. Transforming growth factor-beta1 drives airway remodeling in cigarette smoke-exposed tracheal explants. Am J Respir Cell Mol Biol 2005; 33 (4) 387-393
    CrossrefPubMedGoogle Scholar
  • 79 Casolaro MA, Bernaudin JF, Saltini C, Ferrans VJ, Crystal RG. Accumulation of Langerhans' cells on the epithelial surface of the lower respiratory tract in normal subjects in association with cigarette smoking. Am Rev Respir Dis 1988; 137 (2) 406-411
    CrossrefPubMedGoogle Scholar
  • 80 Tomita K, Caramori G, Lim S , et al. Increased p21(CIP1/WAF1) and B cell lymphoma leukemia-x(L) expression and reduced apoptosis in alveolar macrophages from smokers. Am J Respir Crit Care Med 2002; 166 (5) 724-731
    CrossrefPubMedGoogle Scholar
  • 81 Zeid NA, Muller HK. Tobacco smoke induced lung granulomas and tumors: association with pulmonary Langerhans cells. Pathology 1995; 27 (3) 247-254
    CrossrefPubMedGoogle Scholar
  • 82 Etienne B, Bertocchi M, Gamondes JP , et al. Relapsing pulmonary Langerhans cell histiocytosis after lung transplantation. Am J Respir Crit Care Med 1998; 157 (1) 288-291
    CrossrefPubMedGoogle Scholar